Literature DB >> 26961974

Continuous Glucose Monitoring in Type 1 Diabetes.

Uirassu Borges1, Thomas Kubiak1.   

Abstract

BACKGROUND: Continuous glucose monitoring (CGM) patient systems have been shown to improve diabetes self-treatment when used consistently. The meaningful integration of this technology into everyday life, however, can vary greatly among CGM users and not all people with diabetes use CGM to its full potential. To address this issue, the study pursued 2 aims: first, to identify patient characteristics that underlie the acceptance of CGM in people with type 1 diabetes and, second, to examine the effects of different levels of experience with CGM use.
METHODS: Guided by a model based on the technology acceptance model (TAM), structural equation modeling (SEM) was employed to model the patient characteristics as predictors of CGM acceptance. In all, 111 participants (60.4% female, mean = 37.6 years, SD = 11.2) participated in a web-based survey; 40 were current CGM users, 18 were former users and 53 had no experience with CGM systems.
RESULTS: In general, participants evaluated CGM positively; however, the feeling of information overload represented a major barrier to the sustained use of CGM, while perceptions of usefulness and ease of use constituted incentives for using this technology. Moreover, patients without CGM experience imagined more information overload than current users reported. Current users showed more intention to use CGM than former users.
CONCLUSION: This study highlights the importance of CGM user experience for the effective use of this technology.

Entities:  

Keywords:  continuous glucose monitoring (CGM); human factors; structural equation modeling (SEM); technology acceptance model (TAM); type 1 diabetes

Mesh:

Year:  2016        PMID: 26961974      PMCID: PMC5038544          DOI: 10.1177/1932296816634736

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  12 in total

1.  Psychosocial factors associated with use of continuous glucose monitoring.

Authors:  M D Ritholz; A Atakov-Castillo; M Beste; E A Beverly; A Leighton; K Weinger; H Wolpert
Journal:  Diabet Med       Date:  2010-09       Impact factor: 4.359

2.  Advanced statistics: bootstrapping confidence intervals for statistics with "difficult" distributions.

Authors:  Jason S Haukoos; Roger J Lewis
Journal:  Acad Emerg Med       Date:  2005-04       Impact factor: 3.451

Review 3.  The role of human factors in the design and development of an insulin pump.

Authors:  Noel E Schaeffer
Journal:  J Diabetes Sci Technol       Date:  2012-03-01

4.  Primary care physician's attitude towards the German e-health card project--determinants and implications.

Authors:  Nicole Ernstmann; Oliver Ommen; Melanie Neumann; Antje Hammer; Raymond Voltz; Holger Pfaff
Journal:  J Med Syst       Date:  2009-06       Impact factor: 4.460

5.  Psychosocial factors and adherence to continuous glucose monitoring in type 1 diabetes.

Authors:  Signe Schmidt; Anne Katrine Duun-Henriksen; Kirsten Nørgaard
Journal:  J Diabetes Sci Technol       Date:  2012-07-01

6.  Comparative fit indexes in structural models.

Authors:  P M Bentler
Journal:  Psychol Bull       Date:  1990-03       Impact factor: 17.737

Review 7.  Psychosocial assessment of artificial pancreas (AP): commentary and review of existing measures and their applicability in AP research.

Authors:  Katharine D Barnard; Korey K Hood; Jill Weissberg-Benchell; Chris Aldred; Nick Oliver; Lori Laffel
Journal:  Diabetes Technol Ther       Date:  2014-12-30       Impact factor: 6.118

8.  Patients' perception and future acceptance of an artificial pancreas.

Authors:  Arianne C van Bon; Miriam J E Kohinor; Joost B L Hoekstra; Golo von Basum; J Hans deVries
Journal:  J Diabetes Sci Technol       Date:  2010-05-01

9.  Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial.

Authors:  M A O'Connell; S Donath; D N O'Neal; P G Colman; G R Ambler; T W Jones; E A Davis; F J Cameron
Journal:  Diabetologia       Date:  2009-04-25       Impact factor: 10.122

10.  Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes.

Authors:  Roy W Beck; Bruce Buckingham; Kellee Miller; Howard Wolpert; Dongyuan Xing; Jennifer M Block; H Peter Chase; Irl Hirsch; Craig Kollman; Lori Laffel; Jean M Lawrence; Kerry Milaszewski; Katrina J Ruedy; William V Tamborlane
Journal:  Diabetes Care       Date:  2009-08-12       Impact factor: 19.112

View more
  12 in total

Review 1.  Closing the Loop.

Authors:  Revital Nimri; Nathan Murray; Alexander Ochs; Jordan E Pinsker; Eyal Dassau
Journal:  Diabetes Technol Ther       Date:  2017-02       Impact factor: 6.118

2.  Impact of Human Factors Testing on Medical Device Design: Validation of an Automated CGM Sensor Applicator.

Authors:  Robert North; Christine Pospisil; Ryan J Clukey; Christopher G Parkin
Journal:  J Diabetes Sci Technol       Date:  2019-02-14

Review 3.  Psychosocial Aspects of Continuous Glucose Monitoring: Connecting to the Patients' Experience.

Authors:  Thomas Kubiak; Caroline G Mann; Katherine C Barnard; Lutz Heinemann
Journal:  J Diabetes Sci Technol       Date:  2016-06-28

Review 4.  How Can We Realize the Clinical Benefits of Continuous Glucose Monitoring?

Authors:  Ramzi A Ajjan
Journal:  Diabetes Technol Ther       Date:  2017-05       Impact factor: 6.118

Review 5.  Barriers and Facilitators to Diabetes Device Adoption for People with Type 1 Diabetes.

Authors:  Molly L Tanenbaum; Persis V Commissariat
Journal:  Curr Diab Rep       Date:  2022-05-06       Impact factor: 5.430

6.  Diabetes Technological Revolution: Winners and Losers?

Authors:  Katharine D Barnard; Marc D Breton
Journal:  J Diabetes Sci Technol       Date:  2018-07-23

7.  Unexpected Management Behaviors in Adolescents With Type 1 Diabetes Using Sensor-Augmented Pump Therapy.

Authors:  Mary Binsu Abraham; Kristine Heels; Jennifer A Nicholas; Carol Cole; Rebecca Gebert; Julie Klimek; Tracey Jopling; Geoffrey Ambler; Fergus Cameron; Elizabeth Davis; Timothy W Jones
Journal:  J Diabetes Sci Technol       Date:  2018-01-14

8.  Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel study protocol.

Authors:  Lia Bally; Hood Thabit; Martin Tauschmann; Janet M Allen; Sara Hartnell; Malgorzata E Wilinska; Jane Exall; Viki Huegel; Judy Sibayan; Sarah Borgman; Peiyao Cheng; Maxine Blackburn; Julia Lawton; Daniela Elleri; Lalantha Leelarathna; Carlo L Acerini; Fiona Campbell; Viral N Shah; Amy Criego; Mark L Evans; David B Dunger; Craig Kollman; Richard M Bergenstal; Roman Hovorka
Journal:  BMJ Open       Date:  2017-07-13       Impact factor: 2.692

Review 9.  Human Factors and Data Logging Processes With the Use of Advanced Technology for Adults With Type 1 Diabetes: Systematic Integrative Review.

Authors:  Marion Waite; Clare Martin; Rachel Franklin; David Duce; Rachel Harrison
Journal:  JMIR Hum Factors       Date:  2018-03-15

10.  Associations of Time in Range and Other Continuous Glucose Monitoring-Derived Metrics With Well-Being and Patient-Reported Outcomes: Overview and Trends.

Authors:  Dominic Ehrmann; Lilli Priesterroth; Andreas Schmitt; Bernhard Kulzer; Norbert Hermanns
Journal:  Diabetes Spectr       Date:  2021-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.